An investigation of breast cancer risk factors in Cyprus: a case control study

被引:56
作者
Hadjisavvas, Andreas [1 ]
Loizidou, Maria A. [1 ]
Middleton, Nicos [2 ]
Michael, Thalia [1 ]
Papachristoforou, Rena [1 ]
Kakouri, Eleni [3 ]
Daniel, Maria [3 ]
Papadopoulos, Panayiotis [3 ]
Malas, Simon [4 ]
Marcou, Yiola [3 ]
Kyriacou, Kyriacos [1 ]
机构
[1] Cyprus Inst Neurol & Genet, Dept EM Mol Pathol, Nicosia, Cyprus
[2] Cyprus Univ Technol, Dept Nursing, Sch Hlth Sci, Nicosia, Cyprus
[3] Bank Cyprus Oncol Ctr, Nicosia, Cyprus
[4] Limassol Gen Hosp, Dept Oncol, Limassol, Cyprus
来源
BMC CANCER | 2010年 / 10卷
关键词
HORMONE-REPLACEMENT THERAPY; ESTROGEN PLUS PROGESTIN; HEALTHY POSTMENOPAUSAL WOMEN; COLLABORATIVE REANALYSIS; INDIVIDUAL DATA; OVARIAN-CANCER; EPIDEMIOLOGY; BRCA2; DISEASE; IDENTIFICATION;
D O I
10.1186/1471-2407-10-447
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Breast cancer is the most common form of malignancy affecting women worldwide. It is also the leading cancer in females in Cyprus, with approximately 400 new cases diagnosed annually. It is well recognized that genetic variation as well as environmental factors modulate breast cancer risk. The main aim of this study was to assess the strength of associations between recognized risk factors and breast cancer among Cypriot women. This is the first epidemiological investigation on risk factors of breast cancer among the Cypriot female population. Methods: We carried out a case-control study, involving 1,109 breast cancer patients and a group of 1,177 controls who were recruited while participating in the National screening programme for breast cancer. Information on demographic characteristics and potential risk factors were collected from both groups during a standardized interview. Logistic regression analysis was used to assess the strength of the association between each risk factor and breast cancer risk, before and after adjusting for the possible confounding effect of other factors. Results: In multivariable models, family history of breast cancer (OR 1.64, 95% CI 1.23, 2.19) was the strongest predictor of breast cancer risk in the Cypriot population. Late menarche (OR 0.64, 95% CI 0.45, 0.92 among women reaching menarche after the age of 15 vs. before the age of 12) and breastfeeding (OR 0.74, 95% CI 0.59, 0.92) exhibited a strong protective effect. In the case of breastfeeding, the observed effect appeared stronger than the effect of pregnancy alone. Surprisingly, we also observed an inverse association between hormone replacement therapy (HRT) although this may be a product of the retrospective nature of this study. Conclusion: Overall the findings of our study corroborate with the results of previous investigations on descriptive epidemiology of risk factors for breast cancer. This investigation provides important background information for designing detailed studies that aim to improve our understanding of the epidemiology of breast cancer in the Cypriot population, including the study of gene-environment interactions. Furthermore, our study provides the first scientific evidence for formulating targeted campaigns for prevention and early diagnosis of breast cancer in Cyprus.
引用
收藏
页数:10
相关论文
共 35 条
[1]   Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease [J].
Beral, V ;
Bull, D ;
Doll, R ;
Peto, R ;
Reeves, G ;
La Vecchia, C ;
Magnusson, C ;
Miller, T ;
Peterson, B ;
Pike, M ;
Thomas, D ;
van Leeuwen, F .
LANCET, 2002, 360 (9328) :187-195
[2]   Evidence from randomised trials on the long-term effects of hormone replacement therapy [J].
Beral, V ;
Banks, E ;
Reeves, G .
LANCET, 2002, 360 (9337) :942-944
[3]   Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease [J].
Beral, V ;
Bull, D ;
Doll, R ;
Peto, R ;
Reeves, G .
LANCET, 2001, 358 (9291) :1389-1399
[4]  
Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0
[5]  
Beral Valerie, 2003, Lancet, V362, P419
[6]   Influence of estrogen plus progestin on breast, cancer and mammography in healthy postmenopausal women - The Women's Health Initiative Randomized trial [J].
Chlebowski, RT ;
Hendrix, SL ;
Langer, RD ;
Stefanick, ML ;
Gass, M ;
Lane, D ;
Rodabough, RJ ;
Gilligan, MA ;
Cyr, MG ;
Thomson, CA ;
Khandekar, J ;
Petrovitch, H ;
McTiernan, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (24) :3243-3253
[7]   Understanding breast cancer risk - where do we stand in 2005? [J].
Dumitrescu, RG ;
Cotarla, I .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2005, 9 (01) :208-221
[8]   Risk factors for breast cancer in Iran: a case-control study [J].
Ebrahimi, M ;
Vahdaninia, M ;
Montazeri, A .
BREAST CANCER RESEARCH, 2002, 4 (05)
[9]   MORPHOLOGICAL EVALUATION OF CELL TURNOVER IN RELATION TO THE MENSTRUAL-CYCLE IN THE RESTING HUMAN-BREAST [J].
FERGUSON, DJP ;
ANDERSON, TJ .
BRITISH JOURNAL OF CANCER, 1981, 44 (02) :177-181
[10]   Hereditary breast and ovarian cancer in Cyprus:: identification of a founder BRCA2 mutation [J].
Hadjisavvas, A ;
Charalambous, E ;
Adamou, AB ;
Neuhausen, SL ;
Christodoulou, CG ;
Kyriacou, K .
CANCER GENETICS AND CYTOGENETICS, 2004, 151 (02) :152-156